Drreddys Laboratories | RDY - Operating Profit


Drreddys Laboratories reported INR14.33B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Bayer EUR 1.11B 1.65B Dec/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 430M 104M Dec/2024
Novartis USD 4.5B 363M Sep/2025
Pacira USD 3.19M 9.96M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025